Oligonol Supplement Shows Promise for Muscle Health and Heart Risk in Older Adults
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
20 articles
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
A completed trial tests whether phenolic-rich olive oil plus FOS and inulin can reverse sarcopenia and cut cardiovascular risk in 60โ80-year-olds.
McMaster study compares whole milk, skim milk, and almond beverage effects on muscle protein synthesis in aging women.
A completed clinical trial tests whether a prebiotic blend can boost Akkermansia muciniphila and support weight management in metabolic syndrome.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
12-month trial examined whether oral MK-677 could restore youthful growth hormone levels and improve body composition in healthy seniors.
Small study tests whether protein blends can help older adults maintain muscle mass and strength through improved protein synthesis.
Clinical trial tests safety of combined prebiotic-probiotic supplement in 32 healthy participants over 5 months.
Novel KH-1 supplement containing spermidine and probiotics tested for autophagy stimulation and glucose control in 42 prediabetic participants.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Study reveals how newborn care disrupts mothers' circadian rhythms, potentially affecting long-term metabolic health and diabetes risk.
University study tests whether combining probiotics with prebiotics can restore healthy gut bacteria and immune function in people over 65.
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
Small study tests synbiotic supplements to combat age-related immune decline in healthy elderly adults.
GSK's HRV vaccine faces its biggest test yet โ can it prevent severe rotavirus gastroenteritis without raising intussusception risk?
Small study tested optical breast scanner to identify women at risk for hormone therapy-induced breast cancer within months of treatment.
Pfizer's 24-month study of oral growth hormone secretagogue CP-424,391 in 396 at-risk elderly adults was terminated early.
A completed RCT tests whether adding collagen peptides to standard calcium and vitamin D supplementation improves bone density and remodeling markers in women with osteopenia.
70-person trial tested omega-3's effects on irisin and sirtuin-1, key proteins linked to metabolism and aging in diabetic patients.
12-week trial tests supplement combination for improving lipid metabolism and appetite control in overweight middle-aged adults.